New information prompts old question: Is sentinel lymph node sampling equivalent to axillary lymph node dissection?

Journal of Clinical Oncology

Volumn 32, Issue 32, 2014, Pages 3583-3585

  Zellars, Richard Cedric ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL (TOPIC); DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; LETTER; LYMPH NODE DISSECTION; LYMPH NODE IRRADIATION; MASTECTOMY; META ANALYSIS (TOPIC); OVERALL SURVIVAL; PROTOCOL COMPLIANCE; RADIATION FIELD; SENTINEL LYMPH NODE; SYSTEMATIC REVIEW (TOPIC); BREAST; BREAST NEOPLASMS; FEMALE; OUTCOME ASSESSMENT; PROCEDURES; RADIATION RESPONSE;

BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RADIOTHERAPY;

EID: 84911482094     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.57.9946     Document Type: Letter

References (17)

1. Giuliano AE, McCall L, Beitsch P, et al: Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252:426-432, 2010
2. Giuliano AE, Hunt KK, Ballman KV, et al: Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA 305:569-575, 2011
3. Cody HS 3rd: Does the rapid acceptance of ACOSOG Z0011 compromise selection of systemic therapy? Ann Surg Oncol 19:3643-3645, 2012
4. Gainer SM, Hunt KK, Beitsch P, et al: Changing behavior in clinical practice in response to the ACOSOG Z0011 trial: A survey of the American Society of Breast Surgeons. Ann Surg Oncol 19:3152-3158, 2012
5. Massimino KP, Hessman CJ, Ellis MC, et al: Impact of American College of Surgeons Oncology Group Z0011 and National Surgical Adjuvant Breast and Bowel Project B-32 trial results on surgeon practice in the Pacific Northwest. Am J Surg 203:618-622, 2012
6. Jagsi R, Chadha M, Moni J, et al: Radiation field design on the ACOSOG Z0011 (Alliance) trial. J Clin Oncol 32:3600-3606, 2014
7. National Cancer Institute: Breast Cancer Steering Committee. http://www.cancer.gov/aboutnci/organization/ccct/steering-committees/breast-cancer
8. Cady B: Discussions of Z0011. Ann Surg 252:432, 2010
9. Fisher B, Montague E, Redmond C, et al: Comparison of radical mastectomy with alternative treatments for primary breast cancer: A first report of results from a prospective randomized clinical trial. Cancer 39:2827-2839, 1977 (suppl 6)
10. Fisher B, Jeong JH, Anderson S, et al: Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347:567-575, 2002
11. Gupta SK: Intention-to-treat concept: A review. Perspect Clin Res 2:109-112, 2011
12. Snapinn SM: Noninferiority trials. Curr Control Trials Cardiovasc Med 1:19-21, 2000
13. Jones B, Jarvis P, Lewis JA, et al: Trials to assess equivalence: The importance of rigorous methods. BMJ 313:36-39, 1996
14. EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, et al: Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383:2127-2135, 2014
15. Rutgers EJ: Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: Final analysis of the EORTC AMAROS trial (10981/22023). J Clin Oncol 31:43s, 2013 (suppl; abstr LBA1001)
16. Straver ME, Meijnen P, van Tienhoven G, et al: Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol 28:731-737, 2010
17. Whelan TJ, NCIC-CTG MA. 20: An intergroup trial of regional nodal irradiation in early breast cancer. J Clin Oncol 29:80s, 2011 (suppl; abstr LBA1003)